Tumor biomarkers: PSA and beyond
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F12%3A33140644" target="_blank" >RIV/61989592:15110/12:33140644 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Tumor biomarkers: PSA and beyond
Original language description
Laboratory medicine plays an increasingly important role in the management of cancer patients (1,2). In none of the tumors has the advent of biomarkers changed the treatment in a more fundamental way than the introduction of prostate specific antigen (PSA) which has virtually transformed the management of prostate cancer.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
ISSN
1434-6621
e-ISSN
—
Volume of the periodical
50
Issue of the periodical within the volume
11
Country of publishing house
DE - GERMANY
Number of pages
5
Pages from-to
1865-1869
UT code for WoS article
—
EID of the result in the Scopus database
—